Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

From TechCrunch

By Julie Bort

July 16, 2026

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Founders Fund hires former OpenAI exec Ryan Beiermeister (and not because of her ‘Mafia’ skills)

Ryan Beiermeister has joined Founders Fund as a partner, she announced on Monday. Beiermeister is well-known in Silicon Valley for a number of reasons. For one, prior to this role, she spent about two years as VP of Product Policy at OpenAI as it became a household name, shortly after ChatGPT became the fastest-growing app in history.

That career choice ended abruptly in February when she was reportedly fired after objecting to a planned ChatGPT feature called “adult mode,” which was going to allow adults to use the chatbot for erotica. The Wall Street Journal reported that her firing involved an accusation by a male colleague of sexual discrimination, although Beiermeister called any allegation that she discriminated against anyone “absolutely false.” In March, OpenAI reportedly scrapped plans for adult mode.

More recently, Beiermeister has become well-known in Silicon Valley for her skillful strategy in a Founders Fund YouTube show called “Mafia.” The game involves discovering which players are secret Mafia killers before those players can “kill” the rest of the players.

Beiermeister played the game against OpenAI’s Sam Altman, Anduril’s Palmer Luckey, Figma’s Dylan Field, Flexport’s Ryan Petersen, Founders Fund’s Trae Stephens, and several others.

One of the most intense scenes in Episode One involved her and Altman each saying that if they were found dead, it would mean the other was the killer. Those who knew the history laughed.

Some commented on Twitter that maybe the whole Mafia game was really a job interview for her. The game, according to the firm’s chief marketing officer and the game’s MC, Mike Solana (who brought the game to the firm), is often played at Founders Fund retreats.

However, it wasn’t. “Though she is an excellent Mafia player, that wasn’t part of her interview process. She has been close with Trae Stephens since they worked together at Palantir and has been friendly with our team for years,” a Founders Fund spokesperson told TechCrunch.

Though the way Beiermeister played the game — coolly, making analytical observations and arguments about who might be Mafia — couldn’t have hurt her prospects.

Still, Beiermeister has known Trae Stephens for at least a decade. Prior to her role at OpenAI, and at Meta before that, she spent her formative years at Palantir, the big data company founded by the VC firm’s founder, Peter Thiel. Stephens also worked at Palantir in its early days.

Beiermeister says she’s most interested in backing the kinds of startups that Founders Fund is known to gravitate toward.

“The companies that will define the next twenty years are being built in the categories where product engineering is hardest and the stakes are highest — AI infrastructure and agentic systems, defense, energy, climate, biotech, the regulated frontier,” she wrote in a LinkedIn post. “To the founders in these domains, especially if you don’t fit the standard mold: I want to talk to you and my inbox is open.”

View original article on techcrunch.com

Most Recent

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Why Greylock capped its new fund at $1.5B when it says it could have raised more

Why Greylock capped its new fund at $1.5B when it says it could have raised more

By keeping the number of investments to about 25 per fund, Greylock aims to remain what it calls "the most important partner" to its founders.

Jul 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Jul 14, 2026

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

General Catalyst’s Customer Value Fund doesn't make equity investments. It's providing $1 billion for IM8, known for its longevity vitamin drink.

Jul 14, 2026

Similar Posts

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Why Greylock capped its new fund at $1.5B when it says it could have raised more

Why Greylock capped its new fund at $1.5B when it says it could have raised more

By keeping the number of investments to about 25 per fund, Greylock aims to remain what it calls "the most important partner" to its founders.

Jul 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Jul 14, 2026

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

General Catalyst’s Customer Value Fund doesn't make equity investments. It's providing $1 billion for IM8, known for its longevity vitamin drink.

Jul 14, 2026

Most Recent

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Why Greylock capped its new fund at $1.5B when it says it could have raised more

Why Greylock capped its new fund at $1.5B when it says it could have raised more

By keeping the number of investments to about 25 per fund, Greylock aims to remain what it calls "the most important partner" to its founders.

Jul 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Jul 14, 2026

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

General Catalyst’s Customer Value Fund doesn't make equity investments. It's providing $1 billion for IM8, known for its longevity vitamin drink.

Jul 14, 2026

Similar Posts

AI-powered travel agency Fora hits unicorn status, raises $60M

AI-powered travel agency Fora hits unicorn status, raises $60M

Travel agency Fora announced a $60 million Series D round led by Forerunner and Tactile Ventures, valuing the company at $1 billion.

Jul 16, 2026

Why Greylock capped its new fund at $1.5B when it says it could have raised more

Why Greylock capped its new fund at $1.5B when it says it could have raised more

By keeping the number of investments to about 25 per fund, Greylock aims to remain what it calls "the most important partner" to its founders.

Jul 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

The funding discussions point to investor interest in applying AI to make breakthroughs in life sciences.

Jul 14, 2026

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

David Beckham’s health drink startup IM8 takes $1B from General Catalyst’s unusual CVF fund

General Catalyst’s Customer Value Fund doesn't make equity investments. It's providing $1 billion for IM8, known for its longevity vitamin drink.

Jul 14, 2026